Summary
Targeted RNA-sequencing (RNA-Seq) is a highly accurate method for selecting and sequencing specific transcripts of interest and offers both quantitative and qualitative information. Targeted RNA-Seq can be achieved via either enrichment or amplicon-based approaches, both of which enable gene expression analysis in a focused set of genes of interest, with enrichment assays also providing the ability to detect both known and novel gene fusion partners in many sample types.
In the report, we only collect information about the companies who can provide targeted RNA sequencing service.
According to APO Research, The global Targeted RNA Sequencing market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Targeted RNA Sequencing is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Asia-Pacific market for Targeted RNA Sequencing is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The China market for Targeted RNA Sequencing is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Europe market for Targeted RNA Sequencing is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The major global companies of Targeted RNA Sequencing include Thermo Fisher, Illumina, Roche Holdings, BGI, Eurofins, LabCorp, Berry Genomics, Macrogen and GENEWIZ, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
Report Includes
This report presents an overview of global market for Targeted RNA Sequencing, market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Targeted RNA Sequencing, also provides the revenue of main regions and countries. Of the upcoming market potential for Targeted RNA Sequencing, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Targeted RNA Sequencing revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Targeted RNA Sequencing market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Targeted RNA Sequencing revenue, projected growth trends, production technology, application and end-user industry.
Targeted RNA Sequencing segment by Company
Thermo Fisher
Illumina
Roche Holdings
BGI
Eurofins
LabCorp
Berry Genomics
Macrogen
GENEWIZ
Targeted RNA Sequencing segment by Type
Exome Sequencing
Enrichment Sequencing
Amplicon Sequencing
Targeted RNA Sequencing segment by Application
Research Institutes
Hospitals & Clinics
Biotechnology Company
Diagnostic Lab
Targeted RNA Sequencing segment by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Study Objectives
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key players, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Targeted RNA Sequencing market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Targeted RNA Sequencing and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Targeted RNA Sequencing.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Revenue of Targeted RNA Sequencing in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 4: Detailed analysis of Targeted RNA Sequencing company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Targeted RNA Sequencing revenue, gross margin, and recent development, etc.
Chapter 8: North America (US & Canada) by type, by application and by country, revenue for each segment.
Chapter 9: Europe by type, by application and by country, revenue for each segment.
Chapter 10: China type, by application, revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.
Chapter 12: Middle East, Africa, and Latin America type, by application and by country, revenue for each segment.
Chapter 13: The main concluding insights of the report.
1 Market Overview
1.1 Product Definition
1.2 Targeted RNA Sequencing Market by Type
1.2.1 Global Targeted RNA Sequencing Market Size by Type, 2019 VS 2023 VS 2030
1.2.2 Exome Sequencing
1.2.3 Enrichment Sequencing
1.2.4 Amplicon Sequencing
1.3 Targeted RNA Sequencing Market by Application
1.3.1 Global Targeted RNA Sequencing Market Size by Application, 2019 VS 2023 VS 2030
1.3.2 Research Institutes
1.3.3 Hospitals & Clinics
1.3.4 Biotechnology Company
1.3.5 Diagnostic Lab
1.4 Assumptions and Limitations
1.5 Study Goals and Objectives
2 Targeted RNA Sequencing Market Dynamics
2.1 Targeted RNA Sequencing Industry Trends
2.2 Targeted RNA Sequencing Industry Drivers
2.3 Targeted RNA Sequencing Industry Opportunities and Challenges
2.4 Targeted RNA Sequencing Industry Restraints
3 Global Growth Perspective
3.1 Global Targeted RNA Sequencing Market Perspective (2019-2030)
3.2 Global Targeted RNA Sequencing Growth Trends by Region
3.2.1 Global Targeted RNA Sequencing Market Size by Region: 2019 VS 2023 VS 2030
3.2.2 Global Targeted RNA Sequencing Market Size by Region (2019-2024)
3.2.3 Global Targeted RNA Sequencing Market Size by Region (2025-2030)
4 Competitive Landscape by Players
4.1 Global Targeted RNA Sequencing Revenue by Players
4.1.1 Global Targeted RNA Sequencing Revenue by Players (2019-2024)
4.1.2 Global Targeted RNA Sequencing Revenue Market Share by Players (2019-2024)
4.1.3 Global Targeted RNA Sequencing Players Revenue Share Top 10 and Top 5 in 2023
4.2 Global Targeted RNA Sequencing Key Players Ranking, 2022 VS 2023 VS 2024
4.3 Global Targeted RNA Sequencing Key Players Headquarters & Area Served
4.4 Global Targeted RNA Sequencing Players, Product Type & Application
4.5 Global Targeted RNA Sequencing Players Commercialization Time
4.6 Market Competitive Analysis
4.6.1 Global Targeted RNA Sequencing Market CR5 and HHI
4.6.2 Global Top 5 and 10 Targeted RNA Sequencing Players Market Share by Revenue in 2023
4.6.3 2023 Targeted RNA Sequencing Tier 1, Tier 2, and Tier 3
5 Targeted RNA Sequencing Market Size by Type
5.1 Global Targeted RNA Sequencing Revenue by Type (2019 VS 2023 VS 2030)
5.2 Global Targeted RNA Sequencing Revenue by Type (2019-2030)
5.3 Global Targeted RNA Sequencing Revenue Market Share by Type (2019-2030)
6 Targeted RNA Sequencing Market Size by Application
6.1 Global Targeted RNA Sequencing Revenue by Application (2019 VS 2023 VS 2030)
6.2 Global Targeted RNA Sequencing Revenue by Application (2019-2030)
6.3 Global Targeted RNA Sequencing Revenue Market Share by Application (2019-2030)
7 Company Profiles
7.1 Thermo Fisher
7.1.1 Thermo Fisher Comapny Information
7.1.2 Thermo Fisher Business Overview
7.1.3 Thermo Fisher Targeted RNA Sequencing Revenue and Gross Margin (2019-2024)
7.1.4 Thermo Fisher Targeted RNA Sequencing Product Portfolio
7.1.5 Thermo Fisher Recent Developments
7.2 Illumina
7.2.1 Illumina Comapny Information
7.2.2 Illumina Business Overview
7.2.3 Illumina Targeted RNA Sequencing Revenue and Gross Margin (2019-2024)
7.2.4 Illumina Targeted RNA Sequencing Product Portfolio
7.2.5 Illumina Recent Developments
7.3 Roche Holdings
7.3.1 Roche Holdings Comapny Information
7.3.2 Roche Holdings Business Overview
7.3.3 Roche Holdings Targeted RNA Sequencing Revenue and Gross Margin (2019-2024)
7.3.4 Roche Holdings Targeted RNA Sequencing Product Portfolio
7.3.5 Roche Holdings Recent Developments
7.4 BGI
7.4.1 BGI Comapny Information
7.4.2 BGI Business Overview
7.4.3 BGI Targeted RNA Sequencing Revenue and Gross Margin (2019-2024)
7.4.4 BGI Targeted RNA Sequencing Product Portfolio
7.4.5 BGI Recent Developments
7.5 Eurofins
7.5.1 Eurofins Comapny Information
7.5.2 Eurofins Business Overview
7.5.3 Eurofins Targeted RNA Sequencing Revenue and Gross Margin (2019-2024)
7.5.4 Eurofins Targeted RNA Sequencing Product Portfolio
7.5.5 Eurofins Recent Developments
7.6 LabCorp
7.6.1 LabCorp Comapny Information
7.6.2 LabCorp Business Overview
7.6.3 LabCorp Targeted RNA Sequencing Revenue and Gross Margin (2019-2024)
7.6.4 LabCorp Targeted RNA Sequencing Product Portfolio
7.6.5 LabCorp Recent Developments
7.7 Berry Genomics
7.7.1 Berry Genomics Comapny Information
7.7.2 Berry Genomics Business Overview
7.7.3 Berry Genomics Targeted RNA Sequencing Revenue and Gross Margin (2019-2024)
7.7.4 Berry Genomics Targeted RNA Sequencing Product Portfolio
7.7.5 Berry Genomics Recent Developments
7.8 Macrogen
7.8.1 Macrogen Comapny Information
7.8.2 Macrogen Business Overview
7.8.3 Macrogen Targeted RNA Sequencing Revenue and Gross Margin (2019-2024)
7.8.4 Macrogen Targeted RNA Sequencing Product Portfolio
7.8.5 Macrogen Recent Developments
7.9 GENEWIZ
7.9.1 GENEWIZ Comapny Information
7.9.2 GENEWIZ Business Overview
7.9.3 GENEWIZ Targeted RNA Sequencing Revenue and Gross Margin (2019-2024)
7.9.4 GENEWIZ Targeted RNA Sequencing Product Portfolio
7.9.5 GENEWIZ Recent Developments
8 North America
8.1 North America Targeted RNA Sequencing Revenue (2019-2030)
8.2 North America Targeted RNA Sequencing Revenue by Type (2019-2030)
8.2.1 North America Targeted RNA Sequencing Revenue by Type (2019-2024)
8.2.2 North America Targeted RNA Sequencing Revenue by Type (2025-2030)
8.3 North America Targeted RNA Sequencing Revenue Share by Type (2019-2030)
8.4 North America Targeted RNA Sequencing Revenue by Application (2019-2030)
8.4.1 North America Targeted RNA Sequencing Revenue by Application (2019-2024)
8.4.2 North America Targeted RNA Sequencing Revenue by Application (2025-2030)
8.5 North America Targeted RNA Sequencing Revenue Share by Application (2019-2030)
8.6 North America Targeted RNA Sequencing Revenue by Country
8.6.1 North America Targeted RNA Sequencing Revenue by Country (2019 VS 2023 VS 2030)
8.6.2 North America Targeted RNA Sequencing Revenue by Country (2019-2024)
8.6.3 North America Targeted RNA Sequencing Revenue by Country (2025-2030)
8.6.4 U.S.
8.6.5 Canada
9 Europe
9.1 Europe Targeted RNA Sequencing Revenue (2019-2030)
9.2 Europe Targeted RNA Sequencing Revenue by Type (2019-2030)
9.2.1 Europe Targeted RNA Sequencing Revenue by Type (2019-2024)
9.2.2 Europe Targeted RNA Sequencing Revenue by Type (2025-2030)
9.3 Europe Targeted RNA Sequencing Revenue Share by Type (2019-2030)
9.4 Europe Targeted RNA Sequencing Revenue by Application (2019-2030)
9.4.1 Europe Targeted RNA Sequencing Revenue by Application (2019-2024)
9.4.2 Europe Targeted RNA Sequencing Revenue by Application (2025-2030)
9.5 Europe Targeted RNA Sequencing Revenue Share by Application (2019-2030)
9.6 Europe Targeted RNA Sequencing Revenue by Country
9.6.1 Europe Targeted RNA Sequencing Revenue by Country (2019 VS 2023 VS 2030)
9.6.2 Europe Targeted RNA Sequencing Revenue by Country (2019-2024)
9.6.3 Europe Targeted RNA Sequencing Revenue by Country (2025-2030)
9.6.4 Germany
9.6.5 France
9.6.6 U.K.
9.6.7 Italy
9.6.8 Russia
10 China
10.1 China Targeted RNA Sequencing Revenue (2019-2030)
10.2 China Targeted RNA Sequencing Revenue by Type (2019-2030)
10.2.1 China Targeted RNA Sequencing Revenue by Type (2019-2024)
10.2.2 China Targeted RNA Sequencing Revenue by Type (2025-2030)
10.3 China Targeted RNA Sequencing Revenue Share by Type (2019-2030)
10.4 China Targeted RNA Sequencing Revenue by Application (2019-2030)
10.4.1 China Targeted RNA Sequencing Revenue by Application (2019-2024)
10.4.2 China Targeted RNA Sequencing Revenue by Application (2025-2030)
10.5 China Targeted RNA Sequencing Revenue Share by Application (2019-2030)
11 Asia (Excluding China)
11.1 Asia Targeted RNA Sequencing Revenue (2019-2030)
11.2 Asia Targeted RNA Sequencing Revenue by Type (2019-2030)
11.2.1 Asia Targeted RNA Sequencing Revenue by Type (2019-2024)
11.2.2 Asia Targeted RNA Sequencing Revenue by Type (2025-2030)
11.3 Asia Targeted RNA Sequencing Revenue Share by Type (2019-2030)
11.4 Asia Targeted RNA Sequencing Revenue by Application (2019-2030)
11.4.1 Asia Targeted RNA Sequencing Revenue by Application (2019-2024)
11.4.2 Asia Targeted RNA Sequencing Revenue by Application (2025-2030)
11.5 Asia Targeted RNA Sequencing Revenue Share by Application (2019-2030)
11.6 Asia Targeted RNA Sequencing Revenue by Country
11.6.1 Asia Targeted RNA Sequencing Revenue by Country (2019 VS 2023 VS 2030)
11.6.2 Asia Targeted RNA Sequencing Revenue by Country (2019-2024)
11.6.3 Asia Targeted RNA Sequencing Revenue by Country (2025-2030)
11.6.4 Japan
11.6.5 South Korea
11.6.6 India
11.6.7 Australia
11.6.8 China Taiwan
11.6.9 Southeast Asia
12 Middle East, Africa, Latin America
12.1 MEALA Targeted RNA Sequencing Revenue (2019-2030)
12.2 MEALA Targeted RNA Sequencing Revenue by Type (2019-2030)
12.2.1 MEALA Targeted RNA Sequencing Revenue by Type (2019-2024)
12.2.2 MEALA Targeted RNA Sequencing Revenue by Type (2025-2030)
12.3 MEALA Targeted RNA Sequencing Revenue Share by Type (2019-2030)
12.4 MEALA Targeted RNA Sequencing Revenue by Application (2019-2030)
12.4.1 MEALA Targeted RNA Sequencing Revenue by Application (2019-2024)
12.4.2 MEALA Targeted RNA Sequencing Revenue by Application (2025-2030)
12.5 MEALA Targeted RNA Sequencing Revenue Share by Application (2019-2030)
12.6 MEALA Targeted RNA Sequencing Revenue by Country
12.6.1 MEALA Targeted RNA Sequencing Revenue by Country (2019 VS 2023 VS 2030)
12.6.2 MEALA Targeted RNA Sequencing Revenue by Country (2019-2024)
12.6.3 MEALA Targeted RNA Sequencing Revenue by Country (2025-2030)
12.6.4 Mexico
12.6.5 Brazil
12.6.6 Israel
12.6.7 Argentina
12.6.8 Colombia
12.6.9 Turkey
12.6.10 Saudi Arabia
12.6.11 UAE
13 Concluding Insights
14 Appendix
14.1 Reasons for Doing This Study
14.2 Research Methodology
14.3 Research Process
14.4 Authors List of This Report
14.5 Data Source
14.5.1 Secondary Sources
14.5.2 Primary Sources
14.6 Disclaimer
List of Tables
Table 1. Global Targeted RNA Sequencing Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
Table 1. Exome Sequencing Major Manufacturers
Table 2. Enrichment Sequencing Major Manufacturers
Table 3. Amplicon Sequencing Major Manufacturers
Table 4. Global Targeted RNA Sequencing Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030
Table 5. Research Institutes Major Manufacturers
Table 6. Hospitals & Clinics Major Manufacturers
Table 7. Biotechnology Company Major Manufacturers
Table 8. Diagnostic Lab Major Manufacturers
Table 9. Targeted RNA Sequencing Industry Trends
Table 10. Targeted RNA Sequencing Industry Drivers
Table 11. Targeted RNA Sequencing Industry Opportunities and Challenges
Table 12. Targeted RNA Sequencing Industry Restraints
Table 13. Global Targeted RNA Sequencing Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
Table 14. Global Targeted RNA Sequencing Market Size by Region (2019-2024) & (US$ Million)
Table 15. Global Targeted RNA Sequencing Market Share by Region (2019-2024)
Table 16. Global Targeted RNA Sequencing Market Size by Region (2025-2030) & (US$ Million)
Table 17. Global Targeted RNA Sequencing Market Share by Region (2025-2030)
Table 18. Global Targeted RNA Sequencing Revenue by Players (US$ Million) & (2019-2024)
Table 19. Global Targeted RNA Sequencing Revenue Market Share by Players (2019-2024)
Table 20. Global Targeted RNA Sequencing Key Players Ranking, 2022 VS 2023 VS 2024
Table 21. Global Targeted RNA Sequencing Key Players Headquarters & Area Served
Table 22. Global Targeted RNA Sequencing Players, Product Type & Application
Table 23. Global Targeted RNA Sequencing Players Commercialization Time
Table 24. Global Players Market Concentration Ratio (CR5 and HHI)
Table 25. Global Targeted RNA Sequencing by Players Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2023)
Table 26. Global Targeted RNA Sequencing Revenue by Type 2019 VS 2023 VS 2030 (US$ Million)
Table 27. Global Targeted RNA Sequencing Revenue by Type (2019-2024) & (US$ Million)
Table 28. Global Targeted RNA Sequencing Revenue by Type (2025-2030) & (US$ Million)
Table 29. Global Targeted RNA Sequencing Revenue Market Share by Type (2019-2024) & (US$ Million)
Table 30. Global Targeted RNA Sequencing Revenue Market Share by Type (2025-2030) & (US$ Million)
Table 31. Global Targeted RNA Sequencing Revenue by Application 2019 VS 2023 VS 2030 (US$ Million)
Table 32. Global Targeted RNA Sequencing Revenue by Application (2019-2024) & (US$ Million)
Table 33. Global Targeted RNA Sequencing Revenue by Application (2025-2030) & (US$ Million)
Table 34. Global Targeted RNA Sequencing Revenue Market Share by Application (2019-2024) & (US$ Million)
Table 35. Global Targeted RNA Sequencing Revenue Market Share by Application (2025-2030) & (US$ Million)
Table 36. Thermo Fisher Company Information
Table 37. Thermo Fisher Business Overview
Table 38. Thermo Fisher Targeted RNA Sequencing Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 39. Thermo Fisher Targeted RNA Sequencing Product Portfolio
Table 40. Thermo Fisher Recent Development
Table 41. Illumina Company Information
Table 42. Illumina Business Overview
Table 43. Illumina Targeted RNA Sequencing Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 44. Illumina Targeted RNA Sequencing Product Portfolio
Table 45. Illumina Recent Development
Table 46. Roche Holdings Company Information
Table 47. Roche Holdings Business Overview
Table 48. Roche Holdings Targeted RNA Sequencing Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 49. Roche Holdings Targeted RNA Sequencing Product Portfolio
Table 50. Roche Holdings Recent Development
Table 51. BGI Company Information
Table 52. BGI Business Overview
Table 53. BGI Targeted RNA Sequencing Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 54. BGI Targeted RNA Sequencing Product Portfolio
Table 55. BGI Recent Development
Table 56. Eurofins Company Information
Table 57. Eurofins Business Overview
Table 58. Eurofins Targeted RNA Sequencing Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 59. Eurofins Targeted RNA Sequencing Product Portfolio
Table 60. Eurofins Recent Development
Table 61. LabCorp Company Information
Table 62. LabCorp Business Overview
Table 63. LabCorp Targeted RNA Sequencing Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 64. LabCorp Targeted RNA Sequencing Product Portfolio
Table 65. LabCorp Recent Development
Table 66. Berry Genomics Company Information
Table 67. Berry Genomics Business Overview
Table 68. Berry Genomics Targeted RNA Sequencing Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 69. Berry Genomics Targeted RNA Sequencing Product Portfolio
Table 70. Berry Genomics Recent Development
Table 71. Macrogen Company Information
Table 72. Macrogen Business Overview
Table 73. Macrogen Targeted RNA Sequencing Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 74. Macrogen Targeted RNA Sequencing Product Portfolio
Table 75. Macrogen Recent Development
Table 76. GENEWIZ Company Information
Table 77. GENEWIZ Business Overview
Table 78. GENEWIZ Targeted RNA Sequencing Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 79. GENEWIZ Targeted RNA Sequencing Product Portfolio
Table 80. GENEWIZ Recent Development
Table 81. North America Targeted RNA Sequencing Revenue by Type (2019-2024) & (US$ Million)
Table 82. North America Targeted RNA Sequencing Revenue by Application (2019-2024) & (US$ Million)
Table 83. North America Targeted RNA Sequencing Revenue by Country (2019 VS 2023 VS 2030) & (US$ Million)
Table 84. North America Targeted RNA Sequencing Revenue by Country (2019-2024) & (US$ Million)
Table 85. North America Targeted RNA Sequencing Revenue by Country (2025-2030) & (US$ Million)
Table 86. Europe Targeted RNA Sequencing Revenue by Type (2019-2024) & (US$ Million)
Table 87. Europe Targeted RNA Sequencing Revenue by Application (2019-2024) & (US$ Million)
Table 88. Europe Targeted RNA Sequencing Revenue by Country (2019 VS 2023 VS 2030) & (US$ Million)
Table 89. Europe Targeted RNA Sequencing Revenue by Country (2019-2024) & (US$ Million)
Table 90. Europe Targeted RNA Sequencing Revenue by Country (2025-2030) & (US$ Million)
Table 91. China Targeted RNA Sequencing Revenue by Type (2019-2024) & (US$ Million)
Table 92. China Targeted RNA Sequencing Revenue by Application (2019-2024) & (US$ Million)
Table 93. Asia Targeted RNA Sequencing Revenue by Type (2019-2024) & (US$ Million)
Table 94. Asia Targeted RNA Sequencing Revenue by Application (2019-2024) & (US$ Million)
Table 95. Asia Targeted RNA Sequencing Revenue by Country (2019 VS 2023 VS 2030) & (US$ Million)
Table 96. Asia Targeted RNA Sequencing Revenue by Country (2019-2024) & (US$ Million)
Table 97. Asia Targeted RNA Sequencing Revenue by Country (2025-2030) & (US$ Million)
Table 98. MEALA Targeted RNA Sequencing Revenue by Type (2019-2024) & (US$ Million)
Table 99. MEALA Targeted RNA Sequencing Revenue by Application (2019-2024) & (US$ Million)
Table 100. MEALA Targeted RNA Sequencing Revenue by Country (2019 VS 2023 VS 2030) & (US$ Million)
Table 101. MEALA Targeted RNA Sequencing Revenue by Country (2019-2024) & (US$ Million)
Table 102. MEALA Targeted RNA Sequencing Revenue by Country (2025-2030) & (US$ Million)
Table 103. Research Programs/Design for This Report
Table 104. Authors List of This Report
Table 105. Secondary Sources
Table 106. Primary Sources
List of Figures
Figure 1. Targeted RNA Sequencing Product Picture
Figure 2. Global Targeted RNA Sequencing Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
Figure 3. Global Targeted RNA Sequencing Market Size Share 2019 VS 2023 VS 2030
Figure 4. Exome Sequencing Picture
Figure 5. Enrichment Sequencing Picture
Figure 6. Amplicon Sequencing Picture
Figure 7. Global Targeted RNA Sequencing Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030
Figure 8. Global Targeted RNA Sequencing Market Size Share 2019 VS 2023 VS 2030
Figure 9. Research Institutes Picture
Figure 10. Hospitals & Clinics Picture
Figure 11. Biotechnology Company Picture
Figure 12. Diagnostic Lab Picture
Figure 13. Global Targeted RNA Sequencing Market Size (US$ Million) & (2019-2030)
Figure 14. Global Targeted RNA Sequencing Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 15. Global Targeted RNA Sequencing Market Share by Region: 2019 VS 2023 VS 2030
Figure 16. Global Targeted RNA Sequencing Players Revenue Share Top 10 and Top 5 in 2023
Figure 17. Players Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 18. Global Targeted RNA Sequencing Revenue by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 19. Global Targeted RNA Sequencing Revenue Market Share 2019 VS 2023 VS 2030
Figure 20. Global Targeted RNA Sequencing Revenue Market Share by Type (2019-2030)
Figure 21. Global Targeted RNA Sequencing Revenue by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 22. Global Targeted RNA Sequencing Revenue Market Share by Application (2019 VS 2023 VS 2030)
Figure 23. Global Targeted RNA Sequencing Revenue Market Share by Application (2019-2030)
Figure 24. North America Targeted RNA Sequencing Revenue YoY Growth (2019-2030) & (US$ Million)
Figure 25. North America Targeted RNA Sequencing Revenue by Type (2025-2030) & (US$ Million)
Figure 26. North America Targeted RNA Sequencing Revenue Share by Type (2019-2030)
Figure 27. North America Targeted RNA Sequencing Revenue by Application (2025-2030) & (US$ Million)
Figure 28. North America Targeted RNA Sequencing Revenue Share by Application (2019-2030)
Figure 29. North America Targeted RNA Sequencing Revenue Share by Country (2019-2030)
Figure 30. United States Targeted RNA Sequencing Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 31. Canada Targeted RNA Sequencing Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 32. Europe Targeted RNA Sequencing Revenue YoY Growth (2019-2030) & (US$ Million)
Figure 33. Europe Targeted RNA Sequencing Revenue by Type (2025-2030) & (US$ Million)
Figure 34. Europe Targeted RNA Sequencing Revenue Share by Type (2019-2030)
Figure 35. Europe Targeted RNA Sequencing Revenue by Application (2025-2030) & (US$ Million)
Figure 36. Europe Targeted RNA Sequencing Revenue Share by Application (2019-2030)
Figure 37. Europe Targeted RNA Sequencing Revenue Share by Country (2019-2030)
Figure 38. Germany Targeted RNA Sequencing Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 39. France Targeted RNA Sequencing Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 40. U.K. Targeted RNA Sequencing Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 41. Italy Targeted RNA Sequencing Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 42. Russia Targeted RNA Sequencing Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 43. Nordic Countries Targeted RNA Sequencing Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 44. China Targeted RNA Sequencing Revenue YoY Growth (2019-2030) & (US$ Million)
Figure 45. China Targeted RNA Sequencing Revenue by Type (2025-2030) & (US$ Million)
Figure 46. China Targeted RNA Sequencing Revenue Share by Type (2019-2030)
Figure 47. China Targeted RNA Sequencing Revenue by Application (2025-2030) & (US$ Million)
Figure 48. China Targeted RNA Sequencing Revenue Share by Application (2019-2030)
Figure 49. Asia Targeted RNA Sequencing Revenue YoY Growth (2019-2030) & (US$ Million)
Figure 50. Asia Targeted RNA Sequencing Revenue by Type (2025-2030) & (US$ Million)
Figure 51. Asia Targeted RNA Sequencing Revenue Share by Type (2019-2030)
Figure 52. Asia Targeted RNA Sequencing Revenue by Application (2025-2030) & (US$ Million)
Figure 53. Asia Targeted RNA Sequencing Revenue Share by Application (2019-2030)
Figure 54. Asia Targeted RNA Sequencing Revenue Share by Country (2019-2030)
Figure 55. Japan Targeted RNA Sequencing Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 56. South Korea Targeted RNA Sequencing Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 57. India Targeted RNA Sequencing Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 58. Australia Targeted RNA Sequencing Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 59. China Taiwan Targeted RNA Sequencing Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 60. Southeast Asia Targeted RNA Sequencing Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 61. MEALA Targeted RNA Sequencing Revenue YoY Growth (2019-2030) & (US$ Million)
Figure 62. MEALA Targeted RNA Sequencing Revenue by Type (2025-2030) & (US$ Million)
Figure 63. MEALA Targeted RNA Sequencing Revenue Share by Type (2019-2030)
Figure 64. MEALA Targeted RNA Sequencing Revenue by Application (2025-2030) & (US$ Million)
Figure 65. MEALA Targeted RNA Sequencing Revenue Share by Application (2019-2030)
Figure 66. MEALA Targeted RNA Sequencing Revenue Share by Country (2019-2030)
Figure 67. Mexico Targeted RNA Sequencing Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 68. South Korea Targeted RNA Sequencing Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 69. Brazil Targeted RNA Sequencing Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 70. Israel Targeted RNA Sequencing Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 71. Argentina Targeted RNA Sequencing Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 72. Colombia Targeted RNA Sequencing Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 73. Turkey Targeted RNA Sequencing Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 74. Saudi Arabia Targeted RNA Sequencing Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 75. UAE Targeted RNA Sequencing Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 76. Years Considered
Figure 77. Research Process
Figure 78. Key Executives Interviewed
